Xie D - Search Results

1

Fibronectin fragments alter matrix protein synthesis in cartilage tissue cultured in vitro.

Xie D, Hui F, Homandberg GA. Xie D, et al. Arch Biochem Biophys. 1993 Nov 15;307(1):110-8. doi: 10.1006/abbi.1993.1568. Arch Biochem Biophys. 1993. PMID: 8239647

2

Fibronectin fragments bind to and penetrate cartilage tissue resulting in proteinase expression and cartilage damage.

Xie D, Homandberg GA. Xie D, et al. Biochim Biophys Acta. 1993 Sep 8;1182(2):189-96. doi: 10.1016/0925-4439(93)90140-v. Biochim Biophys Acta. 1993. PMID: 8357850

3

Fibronectin fragments in osteoarthritic synovial fluid.

Xie DL, Meyers R, Homandberg GA. Xie DL, et al. J Rheumatol. 1992 Sep;19(9):1448-52. J Rheumatol. 1992. PMID: 1433014

4

Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture.

Homandberg GA, Meyers R, Xie DL. Homandberg GA, et al. Among authors: xie dl. J Biol Chem. 1992 Feb 25;267(6):3597-604. J Biol Chem. 1992. PMID: 1740411 Free article.

5

Cartilage chondrolysis by fibronectin fragments is associated with release of several proteinases: stromelysin plays a major role in chondrolysis.

Xie DL, Hui F, Meyers R, Homandberg GA. Xie DL, et al. Arch Biochem Biophys. 1994 Jun;311(2):205-12. doi: 10.1006/abbi.1994.1228. Arch Biochem Biophys. 1994. PMID: 8203882

6

Release of elastase from monocytes adherent to a fibronectin-gelatin surface.

Xie DL, Meyers R, Homandberg GA. Xie DL, et al. Blood. 1993 Jan 1;81(1):186-92. Blood. 1993. PMID: 8417788 Free article.

7

The amino-terminal 29- and 72-Kd fragments of fibronectin mediate selective monocyte recruitment.

Lohr KM, Kurth CA, Xie DL, Seyer JM, Homandberg GA. Lohr KM, et al. Among authors: xie dl. Blood. 1990 Nov 15;76(10):2117-24. Blood. 1990. PMID: 2242430 Free article.

8

Unraveling the Role of Interfacial Interactions in Electrical Contacts of Atomically Thin Transition-Metal Dichalcogenides.

Gong M, Xie D, Tian Y, Hua Z, Zhang C, Li M, Cao D, Zhou J, Chen X, Shu H. Gong M, et al. Among authors: xie d. ACS Nano. 2025 Jan 23. doi: 10.1021/acsnano.4c15341. Online ahead of print. ACS Nano. 2025. PMID: 39844672

9

The safety, tolerability, pharmacokinetics and pharmacodynamics of an optimized dual GLP-1/GIP receptor agonist (BGM0504) in healthy volunteers: A dose-escalation Phase I study.

Fan Y, Yuan J, Dong L, Yu C, Ding H, Xie D, Guan R, Li R, Zou W, Long S, Chen J, Huang Y, Yang M, He J, Wen W. Fan Y, et al. Among authors: xie d. Diabetes Obes Metab. 2025 Jan 22. doi: 10.1111/dom.16203. Online ahead of print. Diabetes Obes Metab. 2025. PMID: 39840511

10

Stimuli-Responsive Nano Drug Delivery Systems for the Treatment of Neurological Diseases.

Dai XJ, Li WJ, Xie DD, Liu BX, Gong L, Han HH. Dai XJ, et al. Among authors: xie dd. Small. 2025 Jan 22:e2410030. doi: 10.1002/smll.202410030. Online ahead of print. Small. 2025. PMID: 39840482 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,535 results

Search Page

Filters